Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cenderitide in stabilized acute heart failure
NCT00699712Phase 2Completed
- Sponsor
- Nile Therapeutics
- Start
- Jun 2008
- Primary completion
- Dec 2008
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of cenderitide in heart failure (HF), sponsored by Nile Therapeutics. Started Jun 2008; status: completed.
02
Drugs
cenderitide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00699712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00699712.